Role of nitric oxide in sepsis-associated pulmonary edema

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 1, 1999, Pages 252-257

  Hinder, Frank ^a   Stubbe, Henning D ^a   Van Aken, Hugo ^a   Waurick, René ^a   Booke, Michael ^a   Meyer, Jörg ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; INHALATIONAL DRUG ADMINISTRATION; LUNG EDEMA; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHI; SEPSIS; SHEEP; VASODILATATION;

EID: 0032900656     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.1.9806024     Document Type: Article

References (38)

1. McMahon, T. J., L. J. Ignarro, and P. J. Kadowitz. 1993. Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J. Appl. Physiol. 74:1704-1711.
2. Hinder, F., J. Meyer, M. Booke, J. S. Ehardt, J. R. Salsbury, L. D. Traber, and D. L. Traber. 1998. Endogenous NO and the pulmonary microvasculature in healthy sheep and during systemic inflammation. Am. J. Respir. Crit. Care Med. 157:1542-1549.
3. Giaid, A., and D. Saleh. 1995. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333:214-221.
4. Traber, D. L. 1996. Presence and absence of nitric oxide synthase in sepsis. Crit. Care Med. 24:1102-1103.
5. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
6. Shi, Y., H. Q. Li, C. K. Shen, J. H. Wang, S. W. Qin, R. Liu, and J. Pan. 1993. Plasma nitric oxide levels in newborn infants with sepsis. J. Pediatr. 123:435-438.
7. Meyer, J., F. Hinder, J. Stothert, L. D. Traber, D. N. Herndon, J. T. Flynn, and D. L. Traber. 1994. Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J. Appl. Physiol. 76:2785-2793.
8. Kilbourn, R. G., A. Jubran, S. S. Gross, O. W. Griffith, R. Levi, J. Adarns, and R. F. Lodato. 1990. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172:1132-1138.
9. Geroulanos, S., J. Schilling, M. Cakmakci, H. H. Jung, and F. Largiader. 1992. Inhibition of NO synthesis in septic shock (letter), Lancet 339: 435.
10. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558.
11. Lorente, J. A., L. Landin, R. De Pablo, E. Renes, and D. Liste. 1993. L-arginine pathway in the sepsis syndrome. Crit. Care Med. 21:1287-1295.
12. Meyer, J., C. W. Lentz, J. C. Stothert, L. D. Traber, D. N. Herndon, and D. L. Traber. 1994. Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit. Care Med. 22:306-312.
13. Gordon, J. B., and M. L. Tod. 1993. Effects of N-omega-nitro-L-arginine on total and segmental vascular resistances in developing lamb lungs. J. Appl. Physiol. 75:76-85.
14. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.
15. 2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154:1671-1677.
16. Cope, D. K., F. Grimbert, J. M. Downey, and A. E. Taylor. 1992. Pulmonary capillary pressure: a review. Crit. Care Med. 20:1043-1056.
17. Guyton, A. C., C. E. Jones, and T. G. Coleman. 1973. Normal cardiac output and its variations, 2nd edition. In: Circulatory Physiology: Cariac Output and its Regulation. WB Saunders, Philadelphia. 3-20.
18. Lewis, F. R., V. B. Elings. S. L. Hill, and J. M. Christensen. 1982. The measurement of extravascular lung water by thermal-green dye indicator dilution. Ann. N.Y. Acad. Sci. 384:394-410.
19. Myers, J. C., T. E. Reilley, and C. T. Cloutier. 1988. Effect of positive end-expiratory pressure on extravascular lung water in porcine acute respiratory failure. Crit. Cart Med. 16:52-54.
20. Mondejar, E. F., G. V. Mata, A. Cardenas, A. Mansilla, F. Cantalejo, and R. Rivera. 1996. Ventilation with positive end-expiratory pressure reduces extravascular lung water and increases lymphatic flow in hydrostatic pulmonary-edema. Crit. Care Med. 24:1562-1567.
21. Inamura, T., N. Ohnuma, and F. Iwasa. 1988. Protective effect of alpha- human atrial natriuretic polypeptide on chemical-induced edema. Life Sci. 42:403-414.
22. Wickerts, C.-J., J. Jakobsson, C. Frostell, and G. Hedenstierna. 1990. Measurement of extravascular lung water by thermal-dye dilution technique: mechanisms of cardiac output dependence. Intensive Care Med. 16:115-120.
23. Hinder, F., M. Booke, L. D. Traber, N. Matsumoto, K. Nishida, S. Rogers, and D. L. Traber. 1996. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically elevated atrial natriuretic peptide. Crit. Care Med. 24:131-136.
24. Suffredini, A. F., R. E. Fromm, M. M. Parker, M. Brenner, J. A. Kovacs, R. A. Wesley, and J. E. Parrillo. 1989. The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321:280-287.
25. Dal Nogare, A. R. 1991. Septic shock. Am. J. Med Sci. 302:50-65.
26. Nakazawa, H., H. Noda, S. Noshima, J. T. Flynn, L. D. Traber, D. N. Herndon, and D. L. Traber. 1993. Pulmonary transvascular fluid flux and cardiovascular function in sheep with chronic sepsis. J. Appl. Physiol. 75:2521-2528.
27. Meyer, J., L. D. Traber, S. Nelson, C. W. Lentz, H. Nakazawa, D. N. Herndon, H. Noda, and D. L. Traber. 1992. Reversal of the hyperdy namic response to continuous endotoxin administration by inhibition of NO synthesis. J. Appl. Physiol. 73:324-328.
28. Qiao, R.-L., and J. Bhattacharya. 1991. Segmentai barrier properties of the pulmonary microvascular bed. J. Appl. Physiol. 64:2562-2567.
29. Morel, D. R., J. S. Lacroix, A. Hemsen, D. A. Steinig. J. F. Pittet, and J. M. Lundberg. 1989. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur. J. Pharmacol. 167:427-428.
30. Nelson, S. H., J. S. Ehardt, W. Lingnau, D. J. Dehring, L. D. Traber, and D. L. Traber. 1996. Differential effects of prolonged septicemia on isolated pulmonary arteries and veins from sheep. Shuck 5:440-445.
31. Benzing, A., and K. Geiger. 1994. Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury. Acta Anaesthesiol. Scand. 38:640-645.
32. Rossetti, M., H. Guenard, and C. Gabinski. 1996. Effects of nitric oxide inhalation on pulmonary serial vascular resistances in ARDS. Am. J. Respir. Crit. Care Med. 154:1375-1381.
33. Nishina, K., K. Mikawa, Y. Takao, and H. Obara. 1997. Inhaled nitric oxide does not prevent endotoxin-induced lung injury in rabbits. Acta Anaesthesiol. Scand. 41:399-407.
34. Benzing, A., P. Bräutigam, K. Geiger, T. Loop, U. Beyer, and E. Moser. 1995. Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology 83:1153-1161.
35. Benzing, A., G. Mols, U. Beyer, and K. Geiger. 1997. Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide. Acta Anaesthesiol Scand. 41:643-646.
36. Rossaint, R., K. Slama, W. Steudel, H. Gerlach, D. Pappert, S. Veit, and K. Falke. 1995. Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med. 21:197-203.
37. Jia, L., C. Bonaventura, J. Bonaventura, and J. S. Stamler. 1996. S-nitro- sohaemoglobin - a dynamic activity of blood involved in vascular control. Nature 380:221-226.
38. Stamler, J. S., L. Jia, J. P. Eu, T. J. McMahon, I. T. Demchenko, J. Bonaventura, K. Gernert, and C. A. Piantadosi. 1997. Blood flow regulation by S-nitroso-hemoglobin in the physiological oxygen gradient. Science 276:2034-2037.